Martin Samuel Bates Insider Trades & Stock Holdings

SVP AND CFO · Celldex Therapeutics, Inc. · Latest filing Jun 25, 2026

Martin Samuel Bates, SVP AND CFO at Celldex Therapeutics, Inc. has 1 Form 4 trade on file since Jun 25, 2026. Latest filing: acquired 93K shares of $CLDX on Jun 25, 2026.

Trades on file

1

Open-market bought

$0

Open-market sold

$0

Net open-market

$0

Latest filing

Jun 25, 2026

All insider trades by Martin Samuel Bates

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 25, 2026	$CLDX	Buy (Grant or award)	93K	$0	—			+12.6%	+4.6%		SVP AND CFO		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Martin Samuel Bates traded

• $CLDX

Frequently asked questions

What was Martin Samuel Bates's latest insider trade?

acquired 93K shares of $CLDX on Jun 25, 2026.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.